Table 1.
Interleukin (IL)-4 concentration in culture supernatants by coronary artery disease (CAD), Chlamydia status and Helicobacter pylori status.
| IL-4 (pg/ml) (no added C.pn antigen) | IL-4 (pg/ml) (C.pn antigen 10 µg/ml) | ||||
|---|---|---|---|---|---|
| n | Median (95% CI) | P* | Median (95% CI) | P* | |
| CAD | |||||
| None/mild | 50 | 37·4 (12·8, 81·6) | 51·0 (8·7, 136·9) | ||
| Moderate | 51 | 62·1 (14·8, 115·6) | 67·3 (51·8, 125·5) | ||
| Severe | 38 | 140·7 (70·3, 214·7) | 0·006 | 137·5 (67·7, 243·7) | 0·055 |
| Chlamydia status | |||||
| Seropositive | 42 | 108·8 (62·4, 183·5) | 138·1 (69·0, 212·4) | ||
| Seronegative | 97 | 46·0 (20·0, 90·0) | 0·020 | 60·14 (35·3, 113·9) | 0·047 |
| H. pylori status | |||||
| Seropositive | 38 | 74·0 (24·7, 137·8) | 67·0 (17·1, 148·7) | ||
| Seronegative | 101 | 76·2 (35·0, 104·9) | 0·559 | 106·8 (53·7, 132·0) | 0·711 |
Results are expressed as medians and 95% confidence intervals.
*
The non-parametric Kruskal–Wallis test was used to compare IL-4-value across the CAD groups; Z-value from rank sum test was used for Chlamydia groups and H. pylori groups.